BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $714,000 | -9.5% | 8,112 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $789,000 | -12.2% | 8,112 | +1.2% | 0.01% | -18.2% |
| Q4 2020 | $899,000 | +19.7% | 8,012 | -1.1% | 0.01% | +10.0% |
| Q3 2020 | $751,000 | -74.3% | 8,100 | -78.3% | 0.01% | -75.6% |
| Q2 2020 | $2,918,000 | +33.4% | 37,400 | 0.0% | 0.04% | +17.1% |
| Q1 2020 | $2,188,000 | -30.3% | 37,400 | -2.1% | 0.04% | +12.9% |
| Q4 2019 | $3,140,000 | +11.1% | 38,200 | -0.7% | 0.03% | 0.0% |
| Q3 2019 | $2,827,000 | -22.1% | 38,475 | 0.0% | 0.03% | -20.5% |
| Q2 2019 | $3,630,000 | +16.0% | 38,475 | -1.6% | 0.04% | +14.7% |
| Q1 2019 | $3,130,000 | +47.2% | 39,092 | -0.9% | 0.03% | +25.9% |
| Q4 2018 | $2,126,000 | -30.9% | 39,435 | 0.0% | 0.03% | -10.0% |
| Q3 2018 | $3,078,000 | +4297.1% | 39,435 | +3485.0% | 0.03% | +2900.0% |
| Q2 2018 | $70,000 | -30.7% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $101,000 | -41.6% | 1,100 | -52.2% | 0.00% | -50.0% |
| Q4 2017 | $173,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |